Literature DB >> 17680925

Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.

Ralph W Kupka1, Lori L Altshuler, Willem A Nolen, Trisha Suppes, David A Luckenbaugh, Gabriele S Leverich, Mark A Frye, Paul E Keck, Susan L McElroy, Heinz Grunze, Robert M Post.   

Abstract

OBJECTIVES: To assess the proportion of time spent in mania, depression and euthymia in a large cohort of bipolar subjects studied longitudinally, and to investigate depression/mania ratios in patients with bipolar I versus bipolar II disorder.
METHODS: Clinician-adjusted self-ratings of mood were completed daily for one year for naturalistically treated outpatients with bipolar I (n = 405) or bipolar II (n = 102) disorder. Ratings were analyzed for mean time spent euthymic, depressed, manic, hypomanic, and cycling, and the percentages of time spent ill were compared between the two groups.
RESULTS: Percentages of time spent ill for bipolar I versus II patients were: euthymia 47.7% versus 50.2%; depression 36.0% versus 37.0%; hypomania 11.5% versus 9.8%; mania 1.0% versus 0.2%; and cycling 3.7% versus 2.8%. The depression/mania ratio was 2.9 in the bipolar I and 3.8 in bipolar II sub-groups.
CONCLUSIONS: Depression represents the predominant abnormal mood state for treated outpatients with bipolar I and II disorder. In contrast to other studies, we found that depression/mania ratios were of a similar magnitude, suggesting the same tendency towards mood instability in both sub-groups.

Entities:  

Mesh:

Year:  2007        PMID: 17680925     DOI: 10.1111/j.1399-5618.2007.00467.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  74 in total

1.  Psychopharmacological treatment status in outpatients with bipolar disorder: a clinical survey in Germany.

Authors:  Arnim Quante; Sara Zeugmann; Francesca Regen; Annette Engelhardt; Ion-George Anghelescu
Journal:  Psychiatry Investig       Date:  2010-07-09       Impact factor: 2.505

2.  Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.

Authors:  David E Kemp; Stephen J Ganocy; Martin Brecher; Berit X Carlson; Suzanne Edwards; James M Eudicone; Gary Evoniuk; Wim Jansen; Andrew C Leon; Margaret Minkwitz; Andrei Pikalov; Hans H Stassen; Armin Szegedi; Mauricio Tohen; Arjen P P Van Willigenburg; Joseph R Calabrese
Journal:  J Affect Disord       Date:  2010-11-10       Impact factor: 4.839

3.  Illness progression as a function of independent and accumulating poor prognosis factors in outpatients with bipolar disorder in the United States.

Authors:  Robert M Post; Lori L Altshuler; Gabriele S Leverich; Willem A Nolen; Ralph Kupka; Heinz Grunze; Mark A Frye; Trisha Suppes; Susan L McElroy; Paul E Keck; Mike Rowe
Journal:  Prim Care Companion CNS Disord       Date:  2014-12-18

Review 4.  Pharmacological treatment of bipolar depression: qualitative systematic review of double-blind randomized clinical trials.

Authors:  Lucas Spanemberg; Raffael Massuda; Lucas Lovato; Leonardo Paim; Edgar Arrua Vares; Neusa Sica da Rocha; Keila Maria Mendes Ceresér
Journal:  Psychiatr Q       Date:  2012-06

5.  Bipolar II Disorder: Not So Sure It Is Time for Something New.

Authors:  Robert M Post
Journal:  Can J Psychiatry       Date:  2019-05-19       Impact factor: 4.356

Review 6.  Dopamine Receptor Partial Agonists for the Treatment of Bipolar Disorder.

Authors:  Jean-Michel Azorin; Nicolas Simon
Journal:  Drugs       Date:  2019-10       Impact factor: 9.546

7.  Daily Actigraphy Profiles Distinguish Depressive and Interepisode States in Bipolar Disorder.

Authors:  Anda Gershon; Nilam Ram; Sheri L Johnson; Allison G Harvey; Jamie M Zeitzer
Journal:  Clin Psychol Sci       Date:  2015-11-19

8.  Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD Study.

Authors:  Rodrigo Machado-Vieira; David A Luckenbaugh; Elizabeth D Ballard; Ioline D Henter; Mauricio Tohen; Trisha Suppes; Carlos A Zarate
Journal:  Am J Psychiatry       Date:  2016-08-13       Impact factor: 18.112

9.  Cognitive functioning in patients with bipolar disorder: association with depressive symptoms and alcohol use.

Authors:  Marieke J van der Werf-Eldering; Huibert Burger; Esther A E Holthausen; André Aleman; Willem A Nolen
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

Review 10.  Bipolar pathophysiology and development of improved treatments.

Authors:  Charles L Bowden
Journal:  Brain Res       Date:  2008-06-11       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.